GLUT4 (glucose transporter 4) is responsible for the insulininduced uptake of glucose by muscle and fat cells. In nonstimulated (basal) cells, GLUT4 is retained intracellularly, whereas insulin stimulation leads to its translocation from storage compartments towards the cell surface. How GLUT4 is retained intracellularly is largely unknown. Previously, aberrant GLUT4 N-glycosylation has been linked to increased basal cell-surface levels, while N-glycosylation-deficient GLUT4 was found to be quickly degraded. As recycling and degradation of GLUT4 are positively correlated, we hypothesized that incorrect N-glycosylation of GLUT4 might reduce its intracellular retention, resulting in an increased cell-surface recycling, in increased basal cell-surface levels, and in enhanced GLUT4 degradation. In the present study, we have investigated N-glycosylationdeficient GLUT4 in detail in 3T3-L1 preadipocytes, 3T3-L1 adipocytes and L6 myoblasts. We have found no alterations in retention, insulin response, internalization or glucose transport activity. Degradation of the mutant molecule was increased, although once present at the cell surface, its degradation was identical with that of wild-type GLUT4. Our findings indicate that N-glycosylation is important for efficient trafficking of GLUT4 to its proper compartments, but once the transporter has arrived there, N-glycosylation plays no further major role in its intracellular trafficking, nor in its functional activity.
INTRODUCTION
Protein N-glycosylation is a post-translational process which is initiated within the ER (endoplasmic reticulum), but which continues throughout both the ER and Golgi apparatus [1, 2] . Depending on the protein and cell type involved, N-glycosylation has multiple functions. First, N-glycosylation has been welldocumented for its role in the proper folding of proteins and the associated escape from the ERAD (ER-associated degradation) process [3] . Secondly, N-glycan chains play an active role in the trafficking of certain proteins towards their proper destination within the cell, for example for the lysosomal targeting of acid hydrolases [2] and for the apical targeting in polarized epithelial cells [4] . Thirdly, N-glycans have been suggested to play a regulatory role in endocytosis of cell-surface proteins [5] . Finally, N-glycosylation of proteins may regulate their function, as has been demonstrated for E-cadherin and β1 integrins [6, 7] . Also for GLUT1 (glucose transporter 1), N-glycosylation is likely to modify its function as it has been suggested to regulate its glucose transport activity [8, 9] . Probably related to this effect on transport activity is the change in GLUT1 N-glycosylation upon myogenesis of myoblasts [10] , prolactin and hydrocortisone stimulation [11] , glucose deprivation [12] and tumorigenesis [9, 13] .
GLUT4 has one unique N-glycosylation site. GLUT4 is well known for its unique properties regarding intracellular trafficking, intracellular retention and sensitivity to insulin stimulation [14, 15] . It involves a cell-specific compartment and the functional presence of additional proteins that, at least in part, traffic similarly. In non-stimulated cells, GLUT4 is efficiently retained intracellularly, whereas insulin stimulation leads to its translocation from its storage compartment towards the cell surface. At the cell surface, the GLUT4 N-glycan chain is exposed exofacially, whereas its location is luminal when GLUT4 is inside the cell. Strangely, the role of GLUT4 N-glycosylation has been barely studied. Accordingly, our knowledge on the function of this modification is very limited. There have been four studies that report on GLUT4 N-glycosylation which are discussed in detail below.
In the first study, transduction of primary rat adipocytes with wild-type and N-glycosylation-deficient GLUT4 cDNA resulted in similar mRNA levels, but largely reduced protein amounts of the mutant molecule [16] . This was accompanied by a decrease in metabolic labelling of the mutant, indicating either a reduction in mRNA translation or an increase in its degradation. In our opinion, these results could be explained by a model in which wild-type, but not glycosylation-deficient GLUT4, is efficiently retained intracellularly in adipocytes. GLUT4 lacking its N-glycan chain would therefore be rapidly constitutively recycling via the plasma membrane and endosomes, leading to an increased degradation rate. A close correlation between the intracellular recycling and degradation of GLUT4 is evident from studies that have demonstrated an increased degradation rate of GLUT4 in 3T3-L1 preadipocytes compared with 3T3-L1 adipocytes [17, 18] , and in insulin-stimulated adipocytes compared with non-stimulated adipocytes [19] .
In a second study it has been demonstrated that reducing the expression of the medial Golgi protein Golgin-160 resulted in a large increase in cell-surface GLUT4 levels in 3T3-L1 adipocytes, while disturbing proper GLUT4 N-glycosylation [20] . The authors explained that the altered GLUT4 glycosylation was an indication of the lack of the traffic of GLUT4 through the TGN (trans-Golgi network), which prevented the entry of GLUT4 into insulin-responsive storage vesicles. However, in our opinion, it cannot be excluded that the alteration in GLUT4 N-glycosylation, induced by suppression of Golgin-160, was initiated in the medial Golgi and that this alteration was the primary cause of the mistrafficking of GLUT4 (i.e. prevention of the entry of GLUT4 into its storage compartment or the lack of retention within this compartment).
A third study reported that an increased hexosamine (GlcNAc) flux, known to augment N-glycan branching of glycoproteins, increased cell-surface levels of wild-type, but not glycosylation-deficient, GLUT4 in HEK (human embryonic kidney)-293 cells [5] . It was hypothesized that this increase was due to the increased affinity of the N-glycan chain for the galectins that form a molecular lattice below the plasma membrane which opposes the internalization of glycoproteins such as GLUT4. Nevertheless, it remained to be proven whether GLUT4 N-glycosylation indeed played a role in its internalization.
Finally, more recently, it has been demonstrated that, in HeLa cells (cells that normally do not express GLUT4), Nglycosylation-deficient GLUT4 displays increased cell-surface levels and no longer responds to insulin [21] .
We hypothesized that N-glycosylation of GLUT4 could be implicated in its intracellular trafficking. For the first time, we have used a combination of physiologically relevant cells (adipocyte and muscle cell models) and physiological GLUT4 expression levels to provide a detailed quantitative analysis of various parameters of the trafficking of wild-type and N-glycosylationdeficient GLUT4. The results of the present study demonstrate that N-glycosylation of GLUT4 is dispensable for proper intracellular GLUT4 trafficking, but aids in the efficient targeting of GLUT4 towards its compartments.
EXPERIMENTAL

Materials
3T3-L1 preadipocytes and L6 myoblasts were obtained from the A.T.C.C./LGC Standards. Plat-E cells were provided by Dr Toshio Kitamura (The Institute of Medical Science, University of Tokyo, Tokyo Japan) and the cDNA encoding the retrovirus receptor MMLV (Moloney murine leukaemia virus) was provided by Dr Jonathan Bogan (Yale School of Medicine, Yale University, New Haven, CT, U.S.A.). Newborn and fetal bovine serum were from PAA. Media and Hepes were from Invitrogen. Insulin was from Lilly, a polyclonal anticalnexin antibody was from Stressgen/Enzo Life Sciences, a monoclonal anti-HA (haemagglutinin) antibody (ascites) was from Covance, a goat anti-GLUT4 antibody and HRP (horseradish peroxidase)-conjugated secondary antibodies were from Santa Cruz Biotechnology, IRDye700DX fluorescent secondary antibodies were from Rockland and other fluorescent secondary antibodies were from Invitrogen. The anti-GLUT4 antibody used for immunoprecipitation was raised in rabbits against a peptide corresponding to the GLUT4 C-terminal sequence SLLEQEVKPSTELEYLGPDEND. All other chemicals were from Sigma-Aldrich. Black clear-bottomed well plates were from Greiner Bio-One. The pBABE vector was provided by Dr Hartmut Land (University of Rochester, Rochester, NY, U.S.A.).
Molecular biology and cell culture
The cDNA encoding HA-GLUT4 (GLUT4 with an HA epitope tag in its first luminal domain) inserted into the pBABE-puro vector has been described previously [22] , as well as the cDNA encoding the TfR (transferrin receptor) with an HA-tag at its C-terminus [23] . A pBABE-puro vector containing the cDNA encoding the N-glycosylation-deficient GLUT4 mutant N57Q was constructed by PCR using the oligonucleotides 5 -GATCG-GATCCACCGGTGCCACCATGCCGTCGGGCTTCCAACAG-3 and 3 -GATCCAGCCACGTCTCTTGGTAGCTCTGTTCA-ATC-5 and pBABE-puro-HA-GLUT4 as a template. BamHI and BmgBI restriction enzymes were used to clone the PCR fragment into pBABE-puro-HA-GLUT4. The sequence of the PCR fragment was verified by sequence analysis (Cogenics/Beckman Coulter). The cDNA encoding the retrovirus receptor MMLV was cloned into pcDNA3-Zeo (Invitrogen).
3T3-L1 preadipocytes were cultured and differentiated as described previously [23] . To express HA-GLUT4 in preadipocytes and adipocytes, preadipocytes were infected with retrovirus as described previously [22] , except that Plat-E cells were used for the production of virus [24] . 3T3-L1 preadipocytes were used for experiments 2 days after reaching confluence. Adipocytes were used for experiments 8-12 days after the onset of differentiation, with medium renewed 2 days before the experiment. L6 myoblasts were cultured as described previously [25] , infected with retrovirus for the expression of HA-GLUT4, and used for experiments before reaching confluence. HeLa cells were transfected with pcDNA3-Zeo-MMLV cDNA and individual clones were isolated after zeocin selection. HeLa-MMLV cells were infected with retrovirus for the expression of wild-type and GLUT4-N57Q. Cells were starved for 2 h in serum-free DMEM (Dulbecco's modified Eagle's medium) (3T3-L1 and HeLa cells) or MEMα (minimal essential medium α) (L6 cells) supplemented with 0.2 % BSA before stimulation, unless otherwise stated.
Fluorescence-based techniques
The fluorescence-based assay for the detection of GLUT4 at the cell surface has been described in detail previously [22] . Briefly, HA-GLUT4-expressing cells grown in 96-well plates were fixed and immunolabelled using an anti-HA antibody, after the cells had been incubated in the absence or presence of the permeabilizing agent saponin, to label GLUT4 at the cell surface or total cellular GLUT4 respectively. At the end of the experiments, the 96-well plates were analysed by both a fluorescence microtitre plate reader as well as an epifluorescence microscope to ensure that changes in fluorescence truly represented changes in cell-surface GLUT4 amounts. For antibody-uptake experiments, cells were processed as described in detail previously [26] , except that cells were incubated for 10 min with 7.5 μg/ml anti-HA antibody. Degradation of 'post-Golgi' HA-tagged GLUT4 was measured by incubating non-starved cells for 1 h with 7.5 μg/ml anti-HA antibody in serum-containing medium (pulse), washing the cells twice with medium to remove excess antibody, and incubating the cells further for various time periods with serum-containing medium (chase). Antibodyincubated cells were fixed and labelled with an Alexa Fluor ® 488-conjugated goat-anti-mouse antibody. For all quantitative 96-well plate analyses, control cells (not expressing HA-GLUT4) were included in the studies to determine the non-specific signal. For immunofluorescence microscopy, cells were incubated, fixed and labelled as indicated in the text and visualized using a Carl Zeiss LSM 510 confocal laser-scanning microscope in the C3M (Mediterranean Research Center for Molecular Medicine) Cell Imaging Facility MICA (Nice, France) or a Leica SP5 resonant scanner multi-photon confocal microscope (Leica Microsystems) in the URMITE/CNRS-UMR6020 Department at the Faculty of Medicine (University of the Mediterranean Aix-Marseille II, Marseille, France).
GLUT4 internalization was measured essentially as described by Williams et al. [20] and Berenguer et al. [27] . HA-GLUT4-expressing adipocytes were treated for 30 min with 100 nM insulin, cooled down on ice, washed extensively with PBS and KRM [120 mM NaCl, 6 mM KCl, 1.2 mM MgSO 4 , 20 mM Mes (pH 5.5), 1 mM CaCl 2 and 0.2 % BSA] to remove insulin from its receptor, washed with DMEM containing 20 mM Hepes and 0.2 % BSA (pH 7.4) and incubated on ice for 30 min with an anti-HA antibody in DMEM/Hepes/BSA. The cells were washed again, transferred to a 37
• C waterbath and allowed to internalize antibody for various time periods. Cells were immunolabelled with an Alexa Fluor ® 488-labelled goat-anti-mouse antibody and analysed using the 40× objective on a Zeiss LSM 510 confocal laser-scanning microscope. Images were taken from five different parts of each coverslip and saved in greyscale. Colours were inverted using Adobe Photoshop software. The printed images were analysed and the percentage of anti-HA-positive cells that displayed intracellular label was determined for each image (25-60 cells/image). The results of the five images were averaged. Our previous studies have indicated that the results obtained using this methodology correlate with the relative amount of GLUT4 that is internalized per cell [27] .
N-glycosidase F treatment, cell fractionation and immunoblotting
Cells were lysed in ice-cold buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 10 mM EDTA, 1 % Triton X-100, 100 mM sodium fluoride, 2 mM sodium orthovanadate, 10 mM sodium pyrophosphate and Complete TM protease inhibitor cocktail (Roche). Nuclei and insoluble material were removed by centrifuging for 15 min at 20 000 g at 4
• C. To remove N-linked glycan moieties, 1 unit of N-glycosidase F (Roche) was added to 40 μg of L6 myoblast lysate in a total volume of 40 μl containing 0.05 % Triton X-100, 0.05 % SDS, 75 mM 2-mercaptoethanol, 50 mM EDTA and Complete TM protease inhibitor cocktail in PBS, which was then incubated for 2 h at 37
• C. To isolate cell membrane and cytosol fractions, L6 myoblasts were collected in hypotonic buffer, containing 10 mM Hepes (pH 7.5), 10 mM KCl, 1 mM DTT (dithiothreitol), 20 μM MG132 and Complete TM protease inhibitor cocktail, and sheared 11 times using a 22-gauge needle and 21 times using a 27-gauge needle. Sucrose was slowly added to a concentration of 0.25 M and the PNS (post-nuclear supernatant) was prepared by centrifugation for 10 min at 1300 g at 4
• C. The PNS was centrifuged for 1 h at 45 000 rev./min (rotor Beckman TLA-55) at 4
• C to separate membranes (pellet) from the cytosol (supernatant). Equal amounts of protein were subjected to SDS/PAGE and transferred on to PVDF membranes. Membranes were incubated with the indicated antibodies. HRP-conjugated secondary antibodies were visualized using chemiluminescence reagent (Roche) and a CCD (charge-coupled device) camerabased imager (LAS-3000, Fujifilm) and IRDye700DX antibodies using an Odyssey Infrared Imager (LI-COR Biosciences).
Metabolic labelling and autoradiography
L6 myoblasts were cultured in 6-cm-diameter dishes, washed with PBS, and subsequently incubated for 60 min with pulse medium lacking L-methionine, L-cysteine and serum, and for 12 h in 1.5 ml of pulse medium containing 125 μCi of L-[
35 S]methionine/cysteine per dish (EasyTag, PerkinElmer). After the pulse period, cells were washed three times with PBS and further incubated for various time periods (chase) with serum-containing L6 culture medium to which 100 μg/ml L-methionine and 100 μg/ml L-cysteine were added. After the chase period, the dishes were washed with ice-cold PBS. Lysates were prepared in Triton X-100-containing lysis buffer as described above. The entire lysates were subjected to quantitative immunoprecipitation using a rabbit anti-GLUT4 antibody and Protein A-agarose beads (Roche) in lysis buffer supplemented with 0.5 % SDS and 0.25 % sodium deoxycholate. It appeared to be impossible to use the anti-HA antibody in these experiments due to the low expression levels of the GLUT4 molecules in combination with high background levels in the immunoprecipitations, making it impossible to visualize labelled HA-GLUT4. Immuno-isolated GLUT4 was subjected to SDS/PAGE and the gel was incubated in acetic acid/methanol fixative and scintillator En 3 hance (PerkinElmer). The dried gel was exposed at − 80
• C to Kodak BioMax XAR film which was subsequently developed. Signal was quantified using ImageJ software (NIH).
Glucose uptake
Glucose uptake was measured as described previously [23] . Briefly, L6 myoblasts grown in 12-well plates were incubated for 2 h in MEMα with 0.2 % BSA and for 5 min in KRP [12.5 mM Hepes (pH 7.4), 120 mM NaCl, 6 mM KCl, 1.2 mM MgSO 4 , 1 mM CaCl 2 , 0.4 mM NaH 2 PO 4 , 0.6 mM Na 2 HPO 4 and 0.2 % BSA]. Cells were left untreated or stimulated for 20 min with 100 nM insulin. To control cells, 50 μM cytochalasin B was added 1 min before the addition of 2-deoxyglucose (assay background). Cells were incubated for 3 min with 0.1 mM 2-[ 3 H]deoxyglucose (0.28 μCi/well), extensively washed with ice-cold PBS, and lysed in 1 % Triton X-100. Radioactivity was measured by scintillation counting. 3T3-L1 adipocytes were not used for these experiments as we have been unable to measure an increase in basal and insulinstimulated glucose uptake when we retrovirally expressed wildtype HA-tagged GLUT4 or HA-GLUT4-N57Q in these cells. We assume that this is due to the very low overexpression of GLUT4.
Statistics
All data are presented as means + − S.D. Experiments were repeated at least three times. Western blot analyses of GLUT4 expression levels were repeated six times, GLUT4 translocation in HeLa cells was repeated seven times and metabolic labelling experiments were repeated eight times. Representative experiments are shown. For fluorescence measurements in 96-well plates, four wells were used for each condition. General comparisons between data sets were evaluated using a two-tailed Student's t test and differences between degradation curves (metabolic labelling) were evaluated using one-phase exponential decay curve-fitting with fixed span and plateau parameters (GraphPad Prism). Differences between data sets were considered statistically different when P < 0.05.
RESULTS
The N57Q substitution within GLUT4 abolishes its N-glycosylation and changes its migration pattern on SDS/PAGE
To study the role of N-glycosylation of GLUT4 in its intracellular traffic, we have mutated its unique consensus N-glycosylation site within its first extracellular domain and studied both wild-type and mutant HA-GLUT4 molecules in 3T3-L1 adipocytes and L6 myoblasts. According to our initial hypothesis, N-glycosylationdeficient GLUT4 might not be retained intracellularly in these cell types and rather traffic in a similar manner to the TfR. TfR, in contrast with GLUT4, constitutively recycles via the plasma membrane and its insulin sensitivity is therefore quite limited [23, 28, 29] . Therefore we included two controls in some of our studies. First, HA-tagged TfR was included as a control molecule. Secondly, 3T3-L1 preadipocytes were included as control cells, as it has been shown previously that in these cells GLUT4 is much less efficiently retained intracellularly [30, 31] . As expected, introduction of the N57Q mutation increased the electrophoretic mobility of GLUT4 on SDS/PAGE for all cell types studied (Figure 1 ). In accordance with the results from Ing et al. [16] , we found lower expression levels for the mutant compared with wild-type GLUT4. The anti-GLUT4 blot of the adipocytes displayed almost exclusively endogenous GLUT4 in both lanes, owing to the relatively low expression of both HA-GLUT4 molecules (results not shown). In contrast with wildtype GLUT4, the mutant displayed a major band at 50-55 kDa and some bands of lower molecular mass. These bands were recognized by both anti-HA (first extracellular domain) and anti-GLUT4 (C-terminus) antibodies, implying that the mutant GLUT4 molecule had been partially degraded at its N-terminus. Unfortunately, even though these two bands reacted with both antibodies on Western blot, none of the antibodies were capable of immunoprecipitating either of the bands (results not shown and Figure 4 ). As expected, cell fractionation of L6 myoblasts demonstrated that the partially degraded forms of the mutant were still associated with membranes ( Figure 1B ). This indicates that the degradation of the transporter is initiated while still being present in the membrane. N-glycosidase F treatment of L6 cell lysates not only demonstrated that the GLUT4 mutant had indeed lost its sole carbohydrate moiety, but also that the two lower degradation forms, initially detected for the GLUT4 mutant, were also present for the wild-type molecule, although normally camouflaged by the N-glycan structure ( Figure 1C ). This indicates that the multiple bands of wild-type GLUT4, commonly interpreted as distinct glycosylation forms, represent, at least in part, full-length and partially degraded GLUT4.
Suppression of GLUT4 N-glycosylation does not change cell-surface GLUT4 levels in non-stimulated or insulin-treated 3T3-L1 (pre)adipocytes and L6 myoblasts
Analysing cell-surface amounts of HA-tagged versions of wildtype and GLUT4-N57Q in the absence of insulin or after insulin stimulation, demonstrated that, in both preadipocytes and adipocytes, as well as in L6 myoblasts, wild-type and mutant GLUT4 translocated in response to insulin in a similar fashion (Figure 2 ). Basal cell-surface levels, surface levels in the
Figure 2 Insulin-induced translocation of GLUT4-N57Q is indistinguishable from that of wild-type GLUT4
3T3-L1 preadipocytes (A), adipocytes (B) and L6 myoblasts (C) expressing HA-GLUT4 wild-type or HA-GLUT4-N57Q were stimulated with 100 nM insulin for the indicated time periods. Relative cell-surface levels were determined. Note that the total cellular amount of the N57Q mutant was lower than that of wild-type GLUT4 (not shown), in agreement with Figure 1 . G4, GLUT4; PM, plasma membrane; wt, wild-type. D) expressing the HA-tagged molecules indicated were incubated for 10 min with an anti-HA antibody ('uptake') and labelled with fluorescent secondary antibody. Control cells were immunolabelled with anti-HA after fixation ('post-fixation') in order to detect total cellular levels of the tagged proteins (100 %). Fluorescence was analysed using a confocal laser-scanning microscope (A and B) or a microtitre plate reader (C and D). Scale bar, 10 μm. G4, GLUT4; ins, insulin; wt, wild-type.
Figure 3 Analysis of anti-HA antibody uptake by HA-tagged wild-type GLUT4, GLUT4-N57Q and TfR
3T3-L1 preadipocytes (A and C) and adipocytes (B and
presence of insulin, as well as the kinetics of the appearance of GLUT4 at the cell surface were identical for the two proteins. As it has been described recently that N-glycosylationdeficient GLUT4 does not respond to insulin in HeLa cells [21] , we have included these cells in the present study. These experiments have demonstrated that, even in HeLa cells, cells that normally do not express GLUT4, both wild-type and GLUT4-N57Q appear to respond well to insulin (Supplementary Figure  S1 at http://www.BiochemJ.org/bj/445/bj4450265add.htm).
The intracellular localization and cell-surface recycling of GLUT4 is independent of its N-glycosylation
If the intracellular retention of the non-glycosylated GLUT4 mutant was disturbed, one would expect that cell-surface recycling was increased. To study this possibility, the cells were incubated for 10 min with an anti-HA antibody to allow them to take up the antibody, immunolabelled for the detection of the antibody, and analysed by microscopy ( Figure 3 ). Control cells (lefthand panels) were not pre-incubated with an anti-HA antibody, but immunolabelled with anti-HA after fixation. Neither in preadipocytes ( Figure 3A ) nor in adipocytes ( Figure 3B ) did the mutation cause a clear change in the cellular distribution of GLUT4. There was no evidence for an increase in the localization of the GLUT4 mutant in the ER (see also Supplementary Figure  S2 at http://www.BiochemJ.org/bj/445/bj4450265add.htm), suggesting that N-glycosylation was not particularly implicated in the proper exit of GLUT4 from the ER. Both GLUT4 molecules were located mostly perinuclearly and to some extent also in vesicles dispersed throughout the cytoplasm. In contrast, a large part of the cellular TfR pool was located in cytoplasmically dispersed vesicles, although there existed some perinuclear enrichment. The effect of insulin on antibody uptake by the two GLUT4 molecules was clearly visible in the preadipocytes, but was even more evident in adipocytes where basal antibody uptake was negligible. This microscopic analysis did not show any clear difference between wild-type and mutant GLUT4. The TfR, however, clearly internalized more antibody in both cell types in the absence of insulin, demonstrating its constitutive cell-surface recycling. A quantitative analysis of this uptake by cells cultured in 96-well plates confirmed these results: no difference between wild-type and mutant GLUT4, a reduction in basal cell-surface recycling upon differentiation of the cells, and a higher recycling rate for the TfR in both cell types ( Figures 3C and 3D) .
Abolishing GLUT4 N-glycosylation increases its overall degradation rate, but not its degradation once it has reached the cell surface
As it has been suggested that N-glycosylation-deficient GLUT4 may be rapidly degraded, especially when expressed in adipocytes [16] , we investigated the degradation of fully mature GLUT4 in preadipocytes, adipocytes and myoblasts by incubating HA-GLUT4-and HA-GLUT4-N57Q-expressing cells for 1 h with antibody (pulse) and analysing the degradation of the antibody in time (chase) (Figures 4A-4C ). This method allowed us to study GLUT4 that had passed the Golgi apparatus and that had appeared at the cell surface during the antibody pulse. In accordance with data from others [18, 19] , the GLUT4 half-life was approximately 2 days in adipocytes ( Figure 4B ) and largely reduced in preadipocytes to approximately 12 h ( Figure 4A ). Also in L6 myoblasts, the half-life of GLUT4 was approximately 12 h ( Figure 4C ). In all of these cell types, GLUT4-N57Q was indistinguishable from wild-type GLUT4.
We also assessed the overall degradation rates of wild-type and mutant GLUT4 molecules by metabolic [ 35 S]methionine/cysteine labelling followed by immunoprecipitations (Figures 4D and  4E) . As a cell model, we used L6 myoblasts (that do not express endogenous GLUT4) in combination with anti-GLUT4 immunoprecipitations. This revealed that removal of the N-glycan reduced the half-life from 12 to 5 h.
GLUT4 internalization does not rely on its N-glycosylation
We next investigated endocytosis of wild-type and mutant GLUT4 ( Figure 5 ). Adipocytes expressing HA-GLUT4 or HA-GLUT4-N57Q were grown on coverslips, prelabelled with antibody on ice, washed extensively to remove excess antibody and returned to 37
• C to allow the cells to internalize the GLUT4-bound antibody. This methodology has been successfully used previously to study GLUT4 internalization [20, 32] . The analysis of the coverslips demonstrated that, in time, the amount of cells that started to internalize the antibody after reheating was similar for both GLUT4 molecules, suggesting that the kinetics Figure 5 Internalization rates of wild-type and GLUT4-N57Q are similar Adipocytes, expressing either wild-type or mutant GLUT4, were labelled with an anti-HA antibody at their cell surface and allowed to internalize antibody for various time periods. Adipocytes were fixed and immunolabelled to detect the anti-HA antibody and analysed by immunofluorescence confocal microscopy. The percentage of anti-HA-positive adipocytes that contained intracellular label was determined. G4, GLUT4; wt, wild-type.
of internalization of wild-type and N-glycosylation-deficient GLUT4 were identical.
N-glycosylation of GLUT4 plays no role in the glucose transport activity of GLUT4
Considering that N-glycosylation of GLUT1 appears to be implicated in its functional activity (i.e. glucose transport), we have investigated whether the same holds true for GLUT4 ( Figure 6 ). Therefore using L6 myoblasts as a cell model, we quantitatively measured cell-surface levels of HA-GLUT4 and HA-GLUT4-N57Q as well as the uptake of glucose (2-deoxyglucose) in cells expressing these molecules. As usual, the total cellular expression level of the mutant was lower than that of wild-type GLUT4 ( Figure 6A ). Nevertheless, both molecules efficiently translocated towards the cell surface in Figure 6 The glucose transport activity of wild-type and GLUT4-N57Q is identical L6 myoblasts expressing wild-type GLUT4 or GLUT4-N57Q and control myoblasts were incubated for 20 min in the absence or presence of 100 nM insulin, permeabilized and labelled with an anti-HA antibody to determine their relative expression levels (A), or immunolabelled for the HA tag without permeabilization in order to measure relative cell-surface amounts (B). Parallel cultures were used to measure 2-deoxyglucose (2DG) uptake (C). The results in (B) and (C) were corrected for background (GLUT4-independent) signal and used to calculate the net 2DG uptake per cell-surface GLUT4 molecule (D). A.U., arbitrary units; Ins, insulin; PM, plasma membrane; wt, wild-type.
response to insulin ( Figure 6B ). In parallel, in cells expressing wild-type GLUT4 as well as in cells expressing the mutant molecule, glucose uptake was largely increased compared with cells that did not express any of these molecules and moreover, in all three cell populations, the uptake was insulin-responsive ( Figure 6C ). Calculating the relative amount of glucose uptake per cell-surface HA-GLUT4 molecule (correcting both parameters for background signal) revealed that, at least in L6 myoblasts, glucose transport activity did not differ between wild-type and mutant GLUT4, nor between basal and insulin-stimulated cells ( Figure 6D ). These results clearly indicate that N-glycosylation of GLUT4 plays no role in its transport activity.
DISCUSSION
The results of the present study have demonstrated that, in our adipocyte and muscle cell models which express very low amounts of ectopic GLUT4, suppression of GLUT4 N-glycosylation does not significantly change its relative cell-surface levels in basal or insulin-stimulated cells, cell-surface recycling, internalization, nor its degradation once it has reached the plasma membrane. The sole distinction between wild-type and glycosylation-deficient GLUT4 in our cells was their overall degradation rate.
The increased degradation rate probably explains why, in our three cell types, the expression level of the GLUT4 mutant was lower than that of its wild-type counterpart. This is in accordance with the study of Ing et al. [16] , who also found a reduced expression in primary adipocytes, although their reduction was more severe. They concluded that either the rate of mRNA translation was reduced or that the mutant was rapidly degraded, for example by the ERAD machinery due to its incorrect folding. Our findings support the latter explanation. The GLUT4 Nglycosylation site is conserved across species. Moreover, for the entire GLUT family (GLUT1-GLUT14), only the largest extracellular domain contains one or several N-glycosylation sites: the first extracellular domain for GLUT1-5, 7, 9, 11 and 14, and the fifth extracellular domain for GLUT6, 8, 10, 12 and 13. This seems to be dictated by the size of these domains. All domains that contain at least 31 residues have an N-glycosylation site, whereas all extracellular domains that have no potential N-glycosylation site contain no more than 22 residues. Taking all of this into account, it is tempting to speculate that, at least for GLUTs, N-glycosylation facilitates the correct folding of relatively large luminal loops situated in between transmembrane domains. The molecular mechanism by which N-glycosylation prevents the rapid degradation of GLUT4 remains to be established. A first insight into this mechanism may come from metabolic L-[
35 S]methionine labelling studies (as in Figures 4D and 4E ) in which general N-glycosylation inhibitors, such as tunicamycin and amphomycin, are used [33] . In addition, more specific inhibitors can be used (reviewed in [34] ), such as the glucosidase inhibitors castanospermine and deoxynojirimycin [35] , the mannosidase I inhibitors deoxymannojirimycin and kifunensine (compounds that prevent the synthesis of hybrid and complex-type oligosaccharides) [36] , and the mannosidase II inhibitor swainsonine (blocks synthesis of complex, but not hybrid-type, oligosaccharides) [37] . In contrast with tunicamycin and amphomycin, that completely prevent N-glycosylation, the glucosidase and mannosidase inhibitors only modify the molecular structure of the N-glycan chain and therefore provide a good initial approach for determining the role of various N-glycan components (i.e. type of N-glycan structure) in GLUT4 physiology. Some of these inhibitors should enhance degradation of wild-type GLUT4, but not of N-glycosylationdeficient GLUT4. The use of other ER stress-inducing agents in these studies, such as thapsigargin, known to deplete ER calcium levels [38] , may also aid in unraveling this mechanism [39, 40] .
Upon testing our hypothesis that the GLUT4 N-glycan chain could be implicated in intracellular GLUT4 retention, we found that neither cell-surface GLUT4 levels nor cell-surface recycling were altered for the mutant, indicating that N-glycosylation is not likely to play a large role in intracellular GLUT4 retention. These results also contribute to the study by Pessin and co-workers [20] , in which the effects of Golgin-160 knockdown on cell-surface GLUT4 levels were examined. This knockdown largely increased GLUT4 levels at the plasma membrane in basal, but not in insulinstimulated, cells, while modifying the GLUT4 N-glycan chain. The present study supports the assumption of the authors that the altered glycosylation is just a bystander effect and that the changes in cell-surface GLUT4 levels are not directly due to the alteration in glycosylation.
It has been suggested by Lau et al. [5] that GLUT4 N-glycosylation plays an important role in the regulation of the residence time of GLUT4 at the plasma membrane via an interaction of the N-glycan chain with galectins, thereby opposing internalization. However, we have found similar endocytosis rates for wild-type and glycosylation-deficient GLUT4, indicating that in this trafficking event, the GLUT4 N-glycan chain is not largely involved. It should be noted that the conclusions of Lau et al. [5] were on the basis of cells that expressed GLUT4 ectopically and that were treated with very high concentrations of GlcNAc, a donor substrate for N-glycan branching. Therefore it remains to be determined whether intracellular changes in GlcNAc biosynthesis via the hexosamine pathway do take place under physiological conditions and whether these changes affect GLUT4 N-glycosylation, the putative interaction between GLUT4 and galectins, and GLUT4 endocytosis.
Our most prominent results are not in agreement with the recent study of Haga et al. [21] . Those studies, on the basis of HeLa cells, have suggested that the intracellular retention of N-glycosylationdeficient GLUT4 was largely reduced, leading to significant increases in its cell-surface levels in non-stimulated cells and a complete loss of insulin sensitivity. Although the results of Haga et al. [21] are in agreement with the hypothesis we wanted to test (see the Introduction), we did not find changes in intracellular retention or in cell-surface levels for the glycosylation-deficient molecule in our adipocyte and muscle cell models. Since Haga et al. [21] focussed on HeLa cells, we tested whether the discrepancy was due to the different cell model studied and applied our technologies to HeLa cells (Supplementary Figure S1) . Retrovirus-mediated low-level expression in combination with indirect fluorescence detection of cell-surface GLUT4 indicated that N-glycosylation-deficient GLUT4 still responded remarkably well to insulin. However, basal cell-surface levels of the mutant were somewhat higher compared with wild-type GLUT4. Similar to our findings in adipocyte and muscle cell models, total cellular expression of the mutant was lower than that of wild-type GLUT4. Although Haga et al. [21] also noticed the increase in basal cell-surface levels in HeLa cells, they did not detect any insulinresponsiveness for the N-glycosylation-deficient GLUT4 mutant. At present it is difficult to explain these contrasting findings. First, this could be due to differences in expression levels as, in our HeLa cells, GLUT4 was expressed at much lower levels. In the study of Haga et al. [21] , the transfected HeLa cells were selected by means of their EGFP (enhanced green fluorescent protein) fluorescence, whereas our retroviral expression system does not allow enough expression of EGFP proteins in order to visualize them by fluorescence. High GLUT4 expression levels have been shown to induce artefacts [41] . Secondly, Haga et al. [21] used the biotinylation technique to specifically label GLUT4 at the cell surface, whereas we have used an antibody that recognizes GLUT4 at the plasma membrane of non-permeabilized fixed cells in combination with indirect fluorescent labelling. Thirdly, the (clone of) HeLa cells used in the present study and their studies might have been slightly different.
In conclusion, we have demonstrated that, in adipocyte and muscle cell models, the overall degradation rate of Nglycosylation-deficient GLUT4 is increased compared with that of the wild-type molecule, whereas degradation of these two molecules is indistinguishable once they reach the plasma membrane. Moreover, the GLUT4 N-glycan moiety does not appear to play a major role in intracellular GLUT4 traffic or in its functional activity. Therefore we suggest that the sole role of GLUT4 N-glycosylation is to aid in the prevention of its early degradation, possibly due to an improved folding of the molecule, before it reaches its proper compartments from where it can be translocated. The results of the present study have indicated that the N-glycan chain is not likely to be involved in intracellular GLUT4 retention. Hence, it is likely that other structures within the GLUT4 molecule are implicated in its retention and insulin sensitivity. This includes a recently described N-glycanindependent sorting motif within the first extracellular domain of GLUT4 that interacts with the sorting receptor sortilin [42] .
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